The recent national lipid association recommendations: how do they compare to other established dyslipidemia guidelines?
| Autor: | James A. Underberg, Jonathan D. Newman, Laura E. Flink, Eugenia Gianos |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
Alternative medicine MEDLINE Niacin Risk Assessment Patient Care Planning Fatty Acids Omega-3 medicine Humans Lifestyle Therapy Disease management (health) Societies Medical Dyslipidemias business.industry Anticholesteremic Agents Fibric Acids Disease Management medicine.disease Family medicine Practice Guidelines as Topic Hydroxymethylglutaryl-CoA Reductase Inhibitors Cardiology and Cardiovascular Medicine business Risk assessment Risk Reduction Behavior Dyslipidemia |
| Zdroj: | Current atherosclerosis reports. 17(4) |
| ISSN: | 1534-6242 |
| Popis: | The National Lipid Association (NLA) recently released recommendations for the treatment of dyslipidemias. These recommendations have commonalities and differences with those of other major societies with respect to risk assessment, lifestyle therapy, targets of therapy, and the use of non-statin agents. In this review, we compare the basic elements of the guidelines from each major society to provide clinicians with a comprehensive document reviewing the key principles of each. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink